# NIVOPOSTOP (NCT03576417)

> A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03576417
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
- Conditions: Squamous Cell Carcinoma of Head and Neck
- Interventions: Cisplatin; Nivolumab; RT
- Enrollment: 680
- Primary outcome: Disease free survival

## Commentary we found

- X threads: 50
- YouTube: 21
- Podcasts: 16
- X videos: 2

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nivopostop-nct03576417

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03576417", "email": "<work email>"}; the inbox owner confirms by the emailed link.